Category Biology/Biotechnology

Elderly People protected against Respiratory Infections by BCG Vaccine

ACTIVATE: Randomized Clinical Trial of BCG Vaccination Against Infection in the Elderly. Cell, Aug. 31, 2020; DOI: 10.1016/j.cell.2020.08.051

However, the effect of the vaccine specifically against COVID-19 has not been demonstrated. The BCG vaccine, an old treatment originally developed for tuberculosis, has a broad, stimulating effect on the immune system. This gives it an effective preventive action against various infections — possibly also against COVID-19. It is frequently given to children, but in this double-blind randomized clinical study, a collaboration between Radboud University Medical Center and the National and Kapodistrian University of Athens it was shown that elderly people also benefit from it. The results of the study are in Cell.

At Radboudumc, Professor of Expe...

Read More

Unique Antibody Profile sets Gluten Sensitivity apart from Celiac disease

Subclass Profile of IgG Antibody Response to Gluten Differentiates Non-Celiac Gluten Sensitivity from Celiac Disease

Subclass Profile of IgG Antibody Response to Gluten Differentiates Non-Celiac Gluten Sensitivity from Celiac Disease

A new study of the antibodies produced by people with gluten sensitivity may lead to a better way to detect the condition and treat it.
Until recently, many doctors often dismissed the complaints of people who claimed to be sensitive to foods containing gluten but did not have celiac disease, a well-documented autoimmune disease triggered by exposure to the dietary protein found in wheat, rye, and barley.

That view has changed in the past few years, based partly on studies by Armin Alaedini, PhD, assistant professor of medicine at Columbia University Vagelos College of Physicians and Surgeons, that have delved into the biological basis for non-celiac gluten sensitivity.

But ...

Read More

Synthetic Compound could serve as Prototype for Novel Class of Drugs to Treat Neurological Damage

CPTX (orange) combines functional domains present in synaptic organizing proteins in a unique way. The compound was designed to act as a universal buridge builder for excitatory connections between nerve cells. Source: DZNE/Alexander Dityatev

Researchers from the German Center for Neurodegenerative Diseases (DZNE), UK and Japan have developed a neurologically acting protein and tested it in laboratory studies. In mice, the experimental compound ameliorated symptoms of certain neurological injuries and diseases, while on the microscopic level it was able to establish and repair connections between neurons. This proof-of-principle study suggests that biologics, which act on neuronal connectivity, could be of clinical use in the long term. The results are published in the journal Science.

Read More

How Vitamin C could help over 50s retain Muscle Mass

Foods containing vitamin C

New University of East Anglia (UEA) research shows that vitamin C could help over 50s retain muscle mass in later life. The study shows that older people who eat plenty of vitamin C – commonly found in citrus fruits, berries and vegetables – have the best skeletal muscle mass.

This is important because people tend to lose skeletal muscle mass as they get older — leading to sarcopenia (a condition characterised by loss of skeletal muscle mass and function), frailty and reduced quality of life.

Lead researcher Prof Ailsa Welch, from UEA’s Norwich Medical School said: “As people age, they lose skeletal muscle mass and strength.

“People over 50 lose up to one per cent of their skeletal muscle mass each year, and this loss is thought to affect more than 50 million people worldwide.”

“It’s a...

Read More